Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension

被引:5
|
作者
Ta, Hieu T. [1 ,2 ]
Critser, Paul J. [1 ,2 ]
Schafer, Michal [3 ]
Ollberding, Nicholas J. [2 ,4 ]
Taylor, Michael D. [1 ,2 ]
Di Maria, Michael V. [3 ]
Hirsch, Russel [1 ,2 ]
Ivy, D. Dunbar [3 ]
Frank, Benjamin S. [3 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[3] Univ Colorado, Dept Pediat, Sect Cardiol, Aurora, CO 80045 USA
[4] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
基金
美国国家卫生研究院;
关键词
Pediatric pulmonary hypertension; Global function index; Cardiovascular magnetic resonance; VOLUME;
D O I
10.1186/s12968-023-00947-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMultiple right ventricular (RV) metrics have prognostic value in pulmonary hypertension (PH). A cardiac magnetic resonance imaging (CMR) derived global ventricular function index (GFI) provided improved prediction of composite adverse outcome (CAO) in adults with atherosclerosis. GFI has not yet been explored in a PH population. We explored the feasibility of GFI as a predictor of CAO in a pediatric PH population.MethodsTwo center retrospective chart review identified pediatric PH patients undergoing CMR from Jan 2005-June 2021. GFI, defined as the ratio of the stroke volume to the sum of mean ventricular cavity and myocardial volume, was calculated for each patient. CAO was defined as death, lung transplant, Potts shunt, or parenteral prostacyclin initiation after CMR. Cox proportional hazards regression was used to estimate associations and assess model performance between CMR parameters and CAO.ResultsThe cohort comprised 89 patients (54% female, 84% World Health Organization (WHO) Group 1; 70% WHO-FC & LE; 2; and 27% on parenteral prostacyclin). Median age at CMR was 12 years (IQR 8.1-17). Twenty-one (24%) patients experienced CAO during median follow up of 1.5 years. CAO cohort had higher indexed RV volumes (end systolic-145 vs 99 mL/m(2), p = 0.003; end diastolic-89 vs 46 mL/m(2), p = 0.004) and mass (37 vs 24 gm/m(2), p = 0.003), but lower ejection fraction (EF) (42 vs 51%, p < 0.001) and GFI (40 vs 52%, p < 0.001). Higher indexed RV volumes (hazard ratios [HR] 1.01, CI 1.01-1.02), lower RV EF (HR 1.09, CI 1.05-1.12) and lower RV GFI (HR 1.09, CI 1.05-1.11) were associated with increased risk of CAO. In survival analysis, patients with RV GFI < 43% demonstrated decreased event-free survival and increased hazard of CAO compared to those with RV GFI & GE; 43%. In multivariable models, inclusion of GFI provided improved prediction of CAO compared to models incorporating ventricular volumes, mass or EF.ConclusionsRV GFI was associated with CAO in this cohort, and inclusion in multivariable models had increased predictive value compared to RVEF. GFI uses readily available CMR data without additional post-processing and may provide additional prognostic value in pediatric PH patients beyond traditional CMR markers.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Preoperative pulmonary function is associated with left ventricular assist device outcomes
    Kluis, Austin
    Afzal, Aasim
    Milligan, Greg
    DiMaio, J. Michael
    Kabra, Nitin
    Rawitscher, David A.
    George, Timothy J.
    SURGERY IN PRACTICE AND SCIENCE, 2024, 17
  • [32] Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension
    Critser, Paul J.
    Boyer, Debra
    Visner, Gary A.
    Collins, Shane L.
    Fynn-Thompson, Francis
    Mullen, Mary P.
    PEDIATRIC TRANSPLANTATION, 2022, 26 (04)
  • [33] Use of the Myocardial Performance Index to Assess Right Ventricular Function in Infants with Pulmonary Hypertension
    Neil Patel
    John F. Mills
    Michael M. H. Cheung
    Pediatric Cardiology, 2009, 30 : 133 - 137
  • [34] Ventricular Function and Cardio-Ankle Vascular Index in Patients With Pulmonary Artery Hypertension
    Radchenko, Ganna Dmytrivna
    Botsiuk, Yurii Anatoliiovych
    Sirenko, Yuriy Mykolaiyovich
    VASCULAR HEALTH AND RISK MANAGEMENT, 2022, 18 : 889 - 904
  • [35] Use of the Myocardial Performance Index to Assess Right Ventricular Function in Infants with Pulmonary Hypertension
    Patel, Neil
    Mills, John F.
    Cheung, Michael M. H.
    PEDIATRIC CARDIOLOGY, 2009, 30 (02) : 133 - 137
  • [36] Prevalence and Outcomes of Pediatric In-Hospital Cardiac Arrest Associated With Pulmonary Hypertension*
    Morgan, Ryan W.
    Topjian, Alexis A.
    Wang, Yan
    Atkin, Natalie J.
    Kilbaugh, Todd J.
    McGowan, Francis X.
    Berg, Robert A.
    Mercer-Rosa, Laura
    Sutton, Robert M.
    Himebauch, Adam S.
    PEDIATRIC CRITICAL CARE MEDICINE, 2020, 21 (04) : 305 - 313
  • [37] Clinical Characteristics Of Pediatric Pulmonary Hypertension
    Singh, A.
    Rivera-Lebron, B. N.
    Weiner, D. J.
    Feingold, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] LEFT VENTRICULAR GLOBAL FUNCTION INDEX AND BLOOD PRESSURE PARAMETERS IN UNTREATED PATIENTS WITH HYPERTENSION
    Minushkina, Larisa
    Brazhnik, Victoria
    Chumakova, Olga
    Alekhin, Michail
    JOURNAL OF HYPERTENSION, 2021, 39 : E141 - E141
  • [39] Right Ventricular Function in Systemic Sclerosis-associated Pulmonary Arterial Hypertension
    Koestenberger, Martin
    Ravekes, William
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (01) : 90 - 91
  • [40] Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension
    Parikh, Kishan S.
    Dahhan, Talal
    Nicholl, Leigh
    Ruopp, Nicole
    Pomann, Gina-Maria
    Fortin, Terry
    Tapson, Victor F.
    Rajagopal, Sudarshan
    SCIENTIFIC REPORTS, 2019, 9 (1)